Exper Perspectives Logo
  • Home
  • Therapeutic Categories
    • BACK
    • Therapeutic Categories
    • Allergy & Immunology
      • BACK
      • Allergy & Immunology
      • Chronic Spontaneous Urticaria
      • Food Allergies
      • Pediatric Food Allergies
    • Cardiology
      • BACK
      • Cardiology
      • Hypercholesterolemia
      • Lp(a)
    • Dermatology
      • BACK
      • Dermatology
      • Atopic Dermatitis
      • Plaque Psoriasis
    • Endocrinology
      • BACK
      • Endocrinology
      • Type 2 Diabetes
    • Gastroenterology
      • BACK
      • Gastroenterology
      • Crohn's Disease
      • Ulcerative Colitis
    • Hematology
      • BACK
      • Hematology
      • Chronic Immune Thrombocytopenia
      • Paroxysmal Nocturnal Hemoglobinuria
      • Sickle Cell Disease
    • Hepatology
      • BACK
      • Hepatology
      • Liver Fibrosis
    • Infectious Diseases
      • BACK
      • Infectious Diseases
      • Adolescent Vaccinations
      • Adult Vaccinations
      • Influenza
    • Nephrology
      • BACK
      • Nephrology
      • C3 Glomerulopathy
      • IgAN
      • IgAN & C3G
    • Neurology
      • BACK
      • Neurology
      • Alzheimer's Disease
      • Epilepsy
      • Generalized Myasthenia Gravis
      • Insomnia
      • Migraine
      • Multiple Sclerosis
      • Relapsing Multiple Sclerosis
      • Spinal Muscular Atrophy
      • Tuberous Sclerosis Complex
    • Oncology
      • BACK
      • Oncology
      • Acute Myeloid Leukemia
      • Advanced Prostate Cancer
      • Advanced ROS1-positive NSCLC
      • Anemia in MDS
      • Carcinoid Syndrome
      • Chronic Graft-versus-Host Disease
      • Chronic Lymphocytic Leukemia
      • Chronic Myeloid Leukemia
      • Endometrial Cancer
      • Gastroenteropancreatic Neuroendocrine Tumors
      • Gastrointestinal Stromal Tumors
      • HER2+ Breast Cancer
      • HR+ HER2- Breast Cancer
      • HR+/HER2- Early Breast Cancer
      • Locally Advanced Basal Cell Carcinoma
      • Mantle Cell Lymphoma
      • Melanoma
      • Metastatic Breast Cancer
      • Metastatic Pancreatic Cancer
      • Multiple Myeloma
      • Myelofibrosis
      • Myeloproliferative Neoplasms
      • Non-Small Cell Lung Cancer
      • Ovarian Cancer
      • Prostate Cancer
      • PSMA+ mCRPC
      • Relapsed/Refractory Diffuse Large B-Cell Lymphoma
      • Relapsed/Refractory Multiple Myeloma
      • Women's Cancers
    • Ophthalmology
      • BACK
      • Ophthalmology
      • Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    • Osteoporosis
      • BACK
      • Osteoporosis
      • Osteoporosis
    • Psychiatry
      • BACK
      • Psychiatry
      • Major Depressive Disorder
      • Schizophrenia
      • Tardive Dyskinesia
    • Pulmonology
      • BACK
      • Pulmonology
      • Asthma
      • Chronic Obstructive Pulmonary Disease
      • Interstitial Lung Disease
  • Conference Reporter
  • Expert Directory
  • About Expert Perspectives
  • Login/Register

patient care perspectives

Perspectives on the Total Patient Burden of Chronic Graft-versus-Host Disease
Oncology

Perspectives on the Total Patient Burden of Chronic Graft-versus-Host Disease

patient care perspectives
By Robert S. Negrin, MD
Identifying Candidates for Neoadjuvant or Adjuvant Anti-HER2 Therapy
Oncology

Identifying Candidates for Neoadjuvant or Adjuvant Anti-HER2 Therapy

patient care perspectives
By Sara M. Tolaney, MD, MPH
Risk of Macular Atrophy After Long-term Intravitreal Anti-VEGF Therapy
Ophthalmology

Risk of Macular Atrophy After Long-term Intravitreal Anti-VEGF Therapy

patient care perspectives
By SriniVas R. Sadda, MD, FARVO
Immunoglobulin A Nephropathy and Complement 3 Glomerulopathy: Predictors of Progression
Nephrology

Immunoglobulin A Nephropathy and Complement 3 Glomerulopathy: Predictors of Progression

patient care perspectives
By Richard Lafayette, MD, FACP
Early HER2+ Breast Cancer: How Should Pathological Responses to Neoadjuvant Therapy at the Time of Surgery Guide Decisions About Adjuvant Treatment?
Oncology

Early HER2+ Breast Cancer: How Should Pathological Responses to Neoadjuvant Therapy at the Time of Surgery Guide Decisions About Adjuvant Treatment?

patient care perspectives
By Sara M. Tolaney, MD, MPH
Load More   
logo 2026 Expert Perspectives®
Privacy Policy     Terms of Service     About Expert Perspectives

Your California Privacy Rights     Do Not Sell My Personal Information
Login Expert Perspectives
Forgot Password?
or Create an Account
Create an Account
Forgot Password?